Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Positive data could expand use of Novartis’ gene therapy for SMA
Clinical Trials Arena
Friday, January 3, 2025 - 11:02am
tags:
Novartis, gene therapy, SMA, Zolgensma, OAV101 IT
Anteris IPO Helps Bring Minimally Invasive Heart Valve Innovations
Xtalks
Friday, January 3, 2025 - 10:52am
tags:
Medtech, Anteris, IPOs, heart valve
Regeneron acquires UK biotech, adding Oxular's eye disease delivery tech to portfolio
Fierce Biotech
Friday, January 3, 2025 - 10:51am
tags:
Regeneron, M&A, Oxular, retinal disease
Xgene’s non-opioid analgesic reduces pain in Phase IIb trial
Clinical Trials Arena
Friday, January 3, 2025 - 10:50am
tags:
Xgene, clinical trials, post-surgical pain, XG005
Abbott, Dexcom settle glucose monitor patent lawsuits
Medtech Dive
Friday, January 3, 2025 - 10:48am
tags:
Medtech, Abbott Labs, DexCom, legal, patents, CGMs
Lilly asks to join GLP-1 compounding lawsuit
BioSpace
Friday, January 3, 2025 - 10:47am
tags:
Eli Lilly, FDA, legal, compounded drugs, GLP-1 agonist
Use of diabetes and anti-obesity drugs surges nationwide
Axios
Friday, January 3, 2025 - 10:07am
tags:
obesity, diabetes, Eli Lilly, Novo Nordisk, Ozempic, Wegovy, Mounjaro, Zepbound, GLP-1 agonist
How pharma was instrumental in President Jimmy Carter’s global health efforts
Pharma Voice
Friday, January 3, 2025 - 9:57am
tags:
Jimmy Carter, Merck, GSK, JNJ, Amgen
CARsgen gets a win for CAR-T in solid tumors
Pharmaphorum
Friday, January 3, 2025 - 9:55am
tags:
CARsgen, solid tumors, satri-cel, CAR-T, China
10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thursday, January 2, 2025 - 11:42am
tags:
clinical trials, Eli Lilly, cardiovascular disease, Arvinas, protein degradation, Vera Therapeutics, IgA nephropathy, Novarts, pelacarsen, Entyvio, IBD, Novo Nordisk, Alzheimer's disease, Beam Therapeutics, sickle cell disease, COMPASS Pathways, psychedelics, Moderna Therapeutics, Verve Therapeutics, high cholesterol
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
BioPharma Dive
Thursday, January 2, 2025 - 11:35am
tags:
FDA, Vertex Pharmaceuticals, Novo Nordisk, Bristol Myers Squibb, Alyftrek, cystic fibrosis, Alhemo, hemophilia, Opdivo Qvantiq, solid tumors
BeiGene, Brii and Ideaya ring in 2025 with deal news, betting billions in biobucks on prospects
Fierce Biotech
Thursday, January 2, 2025 - 11:28am
tags:
BeiGene, Brii Biosciences, IDEAYA Biosciences, biobucks, antibody-drug conjugates
Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China
BioSpace
Thursday, January 2, 2025 - 11:26am
tags:
Roche, China, antibody-drug conjugates, small cell lung cancer
Novartis’ Phase III spinal muscular atrophy therapy trial meets primary endpoint
Clinical Trials Arena
Thursday, January 2, 2025 - 11:25am
tags:
Novartis, clinical trials, gene therapy, spinal muscular atrophy, SMA, OAV101 IT
Merck wins UK approval for lung disease drug acquired in $11 billion deal
MSN/Reuters
Thursday, January 2, 2025 - 11:22am
tags:
Merck, UK, sotatercept, Winrevair, PAH
6 Critical Developments That Could Define the Medical Device Industry in 2025
Medical Devices and Diagnostics Industry
Thursday, January 2, 2025 - 11:20am
tags:
devices, Medtech, Europe, Medtronic, Abbott Labs, CGMs, JNJ, robotic surgery, Donald Trump, M&A
4 companies to watch in the accelerating gene editing race
Pharma Voice
Thursday, January 2, 2025 - 11:18am
tags:
gene editing, AlgenScribe SAS, Broken String Biosciences, Caszyme, CorriXR Therapeutics
Trump tariffs and drug prices: 3 notes
Beckers Hospital Review
Thursday, January 2, 2025 - 11:16am
tags:
Donald Trump, drug pricing, tarriffs, Mexico, Canada, China
Neumora laid low by depression trial failure
Pharmaphorum
Thursday, January 2, 2025 - 11:15am
tags:
Neumora, antidepressants, navacaprant, clinical trials
Flagship-backed AI startup Valo shelves eye disease drug
Pharmaphorum
Thursday, January 2, 2025 - 10:54am
tags:
Valo Health, clinical trials, diabetic retinopathy, OPL-0401, Flagship Pioneering

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.